New Cellulose-Based Plant-Derived Enteric Capsules Redefine Precision Drug Delivery

Jan 07, 2026

Leave a message

Against the backdrop of the global pharmaceutical and health product industry's increasing demand for precision drug delivery and plant-based formulations, two major technological breakthroughs in China's hollow capsule sector have attracted widespread attention. GuangSheng Capsule has launched a new generation of cellulose-based plant-derived enteric capsules, while Scitec Nutrition has introduced its HeartClear™ plant-based uncoated enteric soft capsules. Both products leverage innovative one-step enteric technology to address long-standing pain points in the industry, marking a significant leap in China's high-end capsule manufacturing capabilities.

 

GuangSheng Capsule's newly developed cellulose-based plant-derived enteric capsules stand out with their advanced one-step enteric technology. Unlike traditional enteric capsules that require additional coating processes, this new product achieves precise controlled release through optimized special formula adjustment. Clinical tests have confirmed that the capsules can realize slow release for approximately 2 hours, ensuring that the encapsulated active ingredients bypass the gastric environment and are accurately released in the intestinal tract. This technological advantage effectively fills the gap in refined international capsule delivery scenarios, especially catering to the precise release requirements of drugs and health supplements that are unstable in acidic environments or need targeted absorption in specific intestinal segments.

 

As a 100% plant-derived formulation, the cellulose-based enteric capsules from GuangSheng are free of animal-derived ingredients, making them suitable for vegetarians, vegans, and individuals with religious dietary restrictions. Additionally, the product is equipped with customizable anti-counterfeiting functions, which can achieve batch traceability through undetectable marking methods, providing a reliable guarantee for the safety and authenticity of pharmaceutical and health products. This combination of precision release performance, plant-based safety, and anti-counterfeiting features has enhanced GuangSheng's competitiveness in the high-end international capsule market.

 

Meanwhile, Scitec Nutrition's HeartClear™ plant-based uncoated enteric soft capsules have set a new benchmark in the field of functional health product packaging with their proprietary EnteriClear™ technology. The core highlight of this product lies in its excellent acid resistance without the need for additional enteric coating. The capsule shell, developed based on plant-derived materials, can stably withstand the acidic environment of the stomach (pH 1.2-3.5) without dissolving or leaking, effectively protecting the encapsulated oil-soluble ingredients such as fish oil from degradation by gastric acid.

 

A key pain point in the fish oil supplement industry is the "fishy aftertaste" phenomenon caused by the premature release of fish oil in the stomach. Scitec Nutrition's EnteriClear™ patent technology solves this problem fundamentally. By ensuring that the capsule shell only disintegrates and releases the active ingredients in the intestinal environment, HeartClear™ not only improves the bioavailability of fish oil but also completely eliminates the fishy aftertaste and gastrointestinal discomfort associated with traditional fish oil capsules. This technological innovation has been highly recognized by the health product industry, especially in the high-end omega-3 supplement market.

 

Industry analysts point out that the one-step enteric technology adopted by both products represents the mainstream development trend of the global capsule industry. Compared with traditional multi-step enteric coating processes, one-step technology simplifies production procedures, reduces production costs, and avoids potential quality risks such as uneven coating. With the growing global demand for plant-based, high-safety, and precision drug delivery systems, these two new products are expected to drive the upgrading of the global hollow capsule industry. The market share of plant-based enteric capsules is projected to grow significantly in the coming years, with broad application prospects in pharmaceuticals, health supplements, and functional foods.